Further thought and investigation are needed to reconcile the findings that both mGlu5 NAMs and PAMs can be neuroprotective in rodent models of AD, but it may be that antagonism and agonism of mGlu5 are neuroprotective at different stages of disease progression. This evidence concerns the gene GRM5 and Alzheimer disease.